- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04749290
Effects of an Infant Formula on Growth, Safety and Efficacy for Healthy Term Infants
February 28, 2022 updated by: Bunge Loders Croklaan
Comparative Effects of Cow's Milk Based Infant Formula Containing Both OPO and CPP Versus Non-OPO Formula and Breast Feeding on Growth, Stool Consistency and Bone Strength: A Double-blinded, Randomized and Controlled Study
The purpose of this study is to evaluate that a Cow's Milk Based Infant Formula A2 Containing Both OPO and CPP for healthy term infants supports age-appropriate growth.
In this randomized, controlled trial (RCT), healthy, term, formula-fed (FF) infants will be randomized to one of two infant formulas: a standard, commercially-available infant formula for term infants (CF) or the study formula for term infants (SF) for 16 weeks.
A reference group of human milk-fed infants will also be enrolled.
The primary objective is to compare the growth, tolerance, stool consistency and bone strength of infants randomized to the study infant formula (SF) versus infants randomized to the standard commercial infant formula (CF).
Study Overview
Detailed Description
This study is a randomized, controlled, double-blind, study of healthy term formula fed (FF) infants.
FF infants will be randomized to receive either a study infant formula, formulated for healthy term infants or a commercially available infant formula for healthy term infants.
Infants will consume the formula for a total of 16-weeks; infant growth, tolerance, stool consistency and bone strength will be assessed throughout the study.
Study Type
Interventional
Enrollment (Anticipated)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christin Zhang
- Phone Number: 86 021-63735886
- Email: christin.zhang@sprimmedical.com
Study Locations
-
-
-
Jinhua, China
- Recruiting
- JiangNan Street Community Health Service Center, WuCheng District
-
Contact:
- Shirley Zhu
-
Jinhua, China
- Recruiting
- QiuBin Street Community Health Service Center, WuCheng District
-
Contact:
- Christin Zhang
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 weeks to 1 month (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 30 days of age at randomization, inclusive (day of birth is considered day 0)
- Exclusively formula-fed or partially bottle feeding with intake more than 650 ml /day for at least 3 days prior to randomization
- Exclusively breast fed for at least 7 days prior to randomization
- Singleton birth
- Gestational age of 37-42 weeks (36 weeks and six days is considered 36 weeks of gestational age)
- Birth weight of 2500g to 4000g
- Signed informed consent obtained for infant's participation in the study
- Parent or guardian of infant agrees not to enroll infant in another interventional clinical research study while participating in this study
Exclusion Criteria:
- History of underlying metabolic or chronic disease; congenital malformation; or any other condition which, in the opinion of the Investigator, is likely to interfere with: the ability of the infant to ingest food, the normal growth and development of the infant, or the evaluation of the infant
- Evidence of feeding difficulties or formula intolerance, such as vomiting or poor intake, at time of randomization (at investigator discretion)
- Weight at Visit 1 is <95% of birth weight [(weight at Visit 1÷birth weight) x 100 <95%]
- Infant is immunocompromised (according to a doctor's diagnosis of immunodeficiency such as Combined Immunodeficiencies, DiGeorge Syndrome, Wiskott-Aldrich Syndrome, Severe Congenital Neutropenia and Secondary Immunodeficiencies linked to HIV infection, Down Syndrome or others) and children with known head/brain disease/injury such as Microcephaly, Macrocephaly or others
- Participation in another clinical trial
- Known or increased risk of cow's milk allergy and/ or lactose intolerance (i.e. one of the biological parents and or siblings diagnosed with cow's milk allergy, asthma, hay fever, etc.)
- Having a mother suffering from diabetes during pregnancy
- Use of antibiotics at the time of screening, or during the past two weeks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Study Formula
a Cow's Milk Based Infant Formula Containing Both OPO and CPP for term infants (JunLeBao ZhiZhen)
|
Study infant formula for term infants containing OPO and CPP
|
ACTIVE_COMPARATOR: Comparator Formula
Commercially available infant formula without OPO for term infants (JunLeBao LeChun)
|
Study infant formula for term infants containing OPO and CPP
|
NO_INTERVENTION: Human Milk Reference Group
Human milk
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anthropometric parameters
Time Frame: 1month to 5 months
|
Achieved body length (cm) and rate of gain
|
1month to 5 months
|
Anthropometric parameters
Time Frame: 1month to 5 months
|
Achieved body weight (kg) and rate of gain
|
1month to 5 months
|
Anthropometric parameters
Time Frame: 1month to 5 months
|
Achieved head circumferences (cm) and rate of gain
|
1month to 5 months
|
Stool characteristics
Time Frame: 1 month to 5 months
|
Infant Stool Form Scale to measure stool consistency (Bekkali et al, 2009): 4-point scale as watery (A) soft (B) formed (C) or hard (D)
|
1 month to 5 months
|
Stool characteristics
Time Frame: 1 month to 5 months
|
Infant Stool Form Scale to measure stool amount (Bekkali et al, 2009): 4-pont scale as smear (1), up to 25% (2), 25-50% (3) or >50% (4)
|
1 month to 5 months
|
Stool characteristics
Time Frame: 1 month to 5 months
|
Infant Stool Form Scale to measure stool color (Bellali et al, 2009): 6 categories as yellow (I), orange (II), green (III), brown (IV), meconium (V) or clay-colored (VI)
|
1 month to 5 months
|
Gastrointestinal tract discomfort
Time Frame: 1 month to 5 months
|
frequency of parents observed and documented GI tract discomfort
|
1 month to 5 months
|
Bone Speed Of Sound
Time Frame: at 1 month and 5 months
|
Ultrasound Bone Densitometer (BMD-A3)
|
at 1 month and 5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Formula intake and tolerance (24 hour dietary recall)
Time Frame: 2 months to 5 months
|
ml /day
|
2 months to 5 months
|
Medically-diagnosed adverse events collected throughout the study period
Time Frame: 1 month to 5 months
|
frequency
|
1 month to 5 months
|
Crying and sleep tracking (24 hours recall)
Time Frame: 2 months to 5 months
|
frequency
|
2 months to 5 months
|
Bone Mineral Content/Density
Time Frame: at 5 months
|
DEXA
|
at 5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Xiaoyang Shen, MD, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 1, 2021
Primary Completion (ANTICIPATED)
August 1, 2022
Study Completion (ANTICIPATED)
September 1, 2022
Study Registration Dates
First Submitted
January 30, 2021
First Submitted That Met QC Criteria
February 6, 2021
First Posted (ACTUAL)
February 11, 2021
Study Record Updates
Last Update Posted (ACTUAL)
March 2, 2022
Last Update Submitted That Met QC Criteria
February 28, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 20-SM-09-Bunge-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant Development
-
Société des Produits Nestlé (SPN)RecruitingInfant Development | Growth and Development | Infant Health | Infant Formula | Infant Nutritional Physiological PhenomenaSaudi Arabia
-
University of ArizonaMead Johnson NutritionRecruiting
-
Hugo W. Moser Research Institute at Kennedy Krieger...Johns Hopkins UniversityNot yet recruitingChild Development | Developmental Delay | Infant Development | Language Development
-
Aussie Bubs, Inc.RecruitingInfant DevelopmentUnited States
-
Washington University School of MedicineUniversity of MinnesotaNot yet recruiting
-
Tokat Gaziosmanpasa UniversityRecruiting
-
University of Colorado, DenverRecruiting
-
Children's Hospital Los AngelesWuqu' Kawoq, Maya Health AllianceActive, not recruitingInfant DevelopmentGuatemala
-
ByHeartEnrolling by invitationInfant DevelopmentUnited States
-
Rontis Hellas SANational and Kapodistrian University of Athens; National Hellenic Research...Completed
Clinical Trials on Study Formula
-
ByHeartPaidion Research, Inc.CompletedHealthy | Term InfantsUnited States
-
ByHeartPaidion Research, Inc.CompletedNewborn | InfantsUnited States
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Abbott NutritionCompletedPre-term InfantsUnited States
-
NestléCompleted
-
Abbott NutritionTerminatedGastro-Intestinal ToleranceUnited States
-
Société des Produits Nestlé (SPN)TerminatedInfant DevelopmentUnited Kingdom
-
Peking UniversityHuantai Maternal and Child Health Care HospitalUnknownGastrointestinal Dysfunction | Infant Nutrition DisordersChina